BioSyent (CVE:RX) Stock Crosses Above 50 Day Moving Average – Here’s Why

BioSyent Inc. (CVE:RX)’s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$14.35 and traded as high as C$15.44. BioSyent shares last traded at C$15.35, with a volume of 2,359 shares.

BioSyent Price Performance

The firm has a market capitalization of C$176.48 million, a PE ratio of 20.52 and a beta of 0.93. The company has a debt-to-equity ratio of 2.03, a quick ratio of 6.91 and a current ratio of 5.51. The stock has a fifty day moving average price of C$14.35 and a 200-day moving average price of C$12.63.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.